School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, China.
Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
J Clin Lab Anal. 2022 Nov;36(11):e24732. doi: 10.1002/jcla.24732. Epub 2022 Oct 21.
Inherited AT deficiency is an autosomal-dominant thrombophilic disorder usually caused by various SERPINC1 defects associated with a high risk of recurrent venous thromboembolism. In this article, the phenotype, gene mutation, and molecular pathogenic mechanisms were determined in three pedigrees with inherited AT deficiency.
Coagulation indices were examined on STAGO STA-R-MAX analyzer. The AT:Ag was analyzed by ELISA. All exons and flanking sequences of SERPINC1 were amplified by PCR. AT wild type and three mutant expression plasmids were constructed and then transfected into HEK293FT cells. The expression level of AT protein was analyzed by ELISA and Western blot.
The AT:A and AT:Ag of probands 1 and 3 were decreased to 49% and 52 mg/dL, 38% and 44 mg/dL, respectively. The AT:A of proband 2 was decreased to 32%. The SERPINC1 gene analysis indicated that there was a p.Ile421Thr in proband 1, a p.Leu417Gln in proband 2, and a p.Met252Thr in proband 3, respectively. The AT mRNA expression level of the three mutants was not significantly different from AT-WT by qRT-PCR. The results of ELISA and Western blot tests showed that the AT-M252T and AT-I421T mutants had a higher AT expression than the AT wild type (AT-WT), and the AT protein expression of AT-L417Q mutants had no significant difference compared with AT-WT in the cell lysate. The AT expression levels of AT-M252T and AT-I421T mutants were lower than that of AT-WT, and there was no significant difference between AT-L417Q mutant and AT-WT in the supernatant.
The p.I421T and p.M252T mutations affected the secretion of AT protein leading to type I AT deficiency of probands 1 and 3. The p.Leu417Gln mutation was responsible for the impaired or ineffective activity AT protein in proband 2 and caused type II AT deficiency.
遗传性 AT 缺乏症是一种常染色体显性血栓形成性疾病,通常由各种 SERPINC1 缺陷引起,与复发性静脉血栓栓塞的高风险相关。本文确定了三个遗传性 AT 缺乏症家系的表型、基因突变和分子发病机制。
使用 STAGO STA-R-MAX 分析仪检测凝血指数。通过 ELISA 分析 AT:Ag。通过 PCR 扩增 SERPINC1 的所有外显子和侧翼序列。构建 AT 野生型和三种突变表达质粒,然后转染 HEK293FT 细胞。通过 ELISA 和 Western blot 分析 AT 蛋白的表达水平。
先证者 1 和 3 的 AT:A 和 AT:Ag 分别下降至 49%和 52mg/dL、38%和 44mg/dL。先证者 2 的 AT:A 下降至 32%。SERPINC1 基因分析表明,先证者 1 存在 p.Ile421Thr、先证者 2 存在 p.Leu417Gln 和先证者 3 存在 p.Met252Thr 突变。qRT-PCR 结果显示,三种突变体的 AT mRNA 表达水平与 AT-WT 无显著差异。ELISA 和 Western blot 检测结果表明,AT-M252T 和 AT-I421T 突变体的 AT 表达高于 AT-WT,而 AT-L417Q 突变体的 AT 蛋白表达在细胞裂解物中与 AT-WT 无显著差异。AT-M252T 和 AT-I421T 突变体的 AT 表达水平低于 AT-WT,而 AT-L417Q 突变体与 AT-WT 在上清液中无显著差异。
p.I421T 和 p.M252T 突变影响 AT 蛋白的分泌,导致先证者 1 和 3 为 I 型 AT 缺乏症。p.Leu417Gln 突变导致 AT 蛋白活性受损或无效,导致先证者 2 为 II 型 AT 缺乏症。